SEC Form 4 · accession 0001753159-26-000016
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
AmirAli Talasaz
Officer — Co-Chief Executive Officer · Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 6:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | M | 2,817 | $0.00 | A | 1,884,153 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF1 | Jun 30, 2026 | F | 1,428 | $150.03 | D | 1,882,725 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common Stock | Jul 1, 2026 | M | 23,997 | $0.00 | A | 1,906,722 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common Stock | Jul 1, 2026 | M | 9,715 | $0.00 | A | 1,916,437 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
| Common StockF1 | Jul 1, 2026 | F | 17,086 | $170.77 | D | 1,899,351 | I | Shares held by Talasaz and Eskandari 2017 Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Jun 30, 2026 | M | 2,817 | D | — | — | Common Stock | 2,817 | 5,634 | D |
| Restricted Stock UnitsF4,F3 | $0.00 | Jul 1, 2026 | M | 23,997 | D | — | — | Common Stock | 23,997 | 47,995 | D |
| Restricted Stock UnitsF5,F3 | $0.00 | Jul 1, 2026 | M | 9,715 | D | — | — | Common Stock | 9,715 | 58,296 | D |
Explanation of responses
- F1These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
- F3Not applicable for Restricted Stock Units.
- F4This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.